Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Heterocyclic RIP1 kinase inhibitors

US Patent 11479543 · Granted Oct 25, 2022

Estimated economic value: $3,051,000

Assignee

Inventors

View full patent text on Google Patents →